Population Health Sciences Institute, Faculty of Medicine, Newcastle University, Sir James Spence Building, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, United Kingdom.
Medical Research Council Versus Arthritis Centre for Integrated Research into Musculoskeletal Ageing, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.
Bone. 2021 Nov;152:116068. doi: 10.1016/j.bone.2021.116068. Epub 2021 Jun 22.
Circulating microRNAs (c-miRs) show promise as biomarkers. This systematic review explores their potential association with age-related fracture/osteoporosis (OP), osteoarthritis (OA) and sarcopenia (SP), as well as cross-disease association. Most overlap occurred between OA and OP, suggesting potentially shared microRNA activity. There was little agreement in results across studies. Few reported receiver operating characteristic analysis (ROC) and many identified significant dysregulation in disease, but direction of effect was commonly conflicting. c-miRs with most evidence for consistency in dysregulation included miR-146a, miR-155 and miR-98 for OA (upregulated). Area under the curve (AUC) for miR-146a biomarker performance was AUC 0.92, p = 0.028. miR-125b (AUC 0.76-0.89), miR-100, miR-148a and miR-24 were consistently upregulated in OP. Insufficient evidence exists for c-miRs in SP. Study quality was typically rated intermediate/high risk of bias. Wide study heterogeneity meant meta-analysis was not possible. We provide detailed critique and recommendations for future approaches in c-miR analyses based on this review.
循环 microRNAs(c-miRs)作为生物标志物具有很大的应用前景。本系统综述探讨了它们与年龄相关性骨折/骨质疏松症(OP)、骨关节炎(OA)和肌肉减少症(SP)之间的潜在相关性,以及跨疾病的相关性。OA 和 OP 之间的重叠最多,表明潜在的 miRNA 活性可能存在共享。研究结果之间几乎没有一致性。很少有研究报告接受者操作特征分析(ROC),并且许多研究都发现疾病存在显著的失调,但效应方向通常存在冲突。在失调方面具有最一致证据的 c-miRs 包括 miR-146a、miR-155 和 miR-98 与 OA(上调)有关。miR-146a 生物标志物性能的曲线下面积(AUC)为 AUC 0.92,p=0.028。miR-125b(AUC 0.76-0.89)、miR-100、miR-148a 和 miR-24 在 OP 中均上调。c-miRs 在 SP 中的证据不足。研究质量通常被评为中度/高偏倚风险。研究的高度异质性意味着无法进行荟萃分析。我们根据本综述为 c-miR 分析提供了详细的评价和未来方法的建议。